2don MSN
Dr. Reddy’s Lab launches India’s first DCGI-approved semaglutide injection for type 2 diabetes
Dr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian ...
Health and Me on MSN
Alkem Laboratories launches cheapest semaglutide injection in India
Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced ...
Dr Reddy’s launches Obeda, a generic semaglutide for diabetes management, priced at ₹4,200 per month in India.
Everyday Health on MSN
New Kind of Diabetes Drug Helped People Lower Blood Sugar and Lose Almost 40 Pounds
The first-in-class injectable could be the next big thing in diabetes and obesity treatment.
Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...
Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...
Dr Reddy's Laboratories has announced the launch of its injectable semaglutide under the brand name Obeda, marking an important step in expanding access to GLP-1 receptor agonist-based therapy for the ...
You might have heard about medications like Ozempic®, Mounjaro®, and metformin for weight loss. But these drugs are actually diabetes medications that are sometimes prescribed off-label for weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results